Cargando…

SARS-CoV-2 Seroprevalence in a Rural and Urban Household Cohort during First and Second Waves of Infections, South Africa, July 2020–March 2021

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections may be underestimated because of limited access to testing. We measured SARS-CoV-2 seroprevalence in South Africa every 2 months during July 2020–March 2021 in randomly selected household cohorts in 2 communities. We compared se...

Descripción completa

Detalles Bibliográficos
Autores principales: Kleynhans, Jackie, Tempia, Stefano, Wolter, Nicole, von Gottberg, Anne, Bhiman, Jinal N., Buys, Amelia, Moyes, Jocelyn, McMorrow, Meredith L., Kahn, Kathleen, Gómez-Olivé, F. Xavier, Tollman, Stephen, Martinson, Neil A., Wafawanaka, Floidy, Lebina, Limakatso, du Toit, Jacques, Jassat, Waasila, Neti, Mzimasi, Brauer, Marieke, Cohen, Cheryl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632160/
https://www.ncbi.nlm.nih.gov/pubmed/34477548
http://dx.doi.org/10.3201/eid2712.211465
_version_ 1784607701071822848
author Kleynhans, Jackie
Tempia, Stefano
Wolter, Nicole
von Gottberg, Anne
Bhiman, Jinal N.
Buys, Amelia
Moyes, Jocelyn
McMorrow, Meredith L.
Kahn, Kathleen
Gómez-Olivé, F. Xavier
Tollman, Stephen
Martinson, Neil A.
Wafawanaka, Floidy
Lebina, Limakatso
du Toit, Jacques
Jassat, Waasila
Neti, Mzimasi
Brauer, Marieke
Cohen, Cheryl
author_facet Kleynhans, Jackie
Tempia, Stefano
Wolter, Nicole
von Gottberg, Anne
Bhiman, Jinal N.
Buys, Amelia
Moyes, Jocelyn
McMorrow, Meredith L.
Kahn, Kathleen
Gómez-Olivé, F. Xavier
Tollman, Stephen
Martinson, Neil A.
Wafawanaka, Floidy
Lebina, Limakatso
du Toit, Jacques
Jassat, Waasila
Neti, Mzimasi
Brauer, Marieke
Cohen, Cheryl
author_sort Kleynhans, Jackie
collection PubMed
description Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections may be underestimated because of limited access to testing. We measured SARS-CoV-2 seroprevalence in South Africa every 2 months during July 2020–March 2021 in randomly selected household cohorts in 2 communities. We compared seroprevalence to reported laboratory-confirmed infections, hospitalizations, and deaths to calculate infection–case, infection–hospitalization, and infection–fatality ratios in 2 waves of infection. Post–second wave seroprevalence ranged from 18% in the rural community children <5 years of age, to 59% in urban community adults 35–59 years of age. The second wave saw a shift in age distribution of case-patients in the urban community (from persons 35–59 years of age to persons at the extremes of age), higher attack rates in the rural community, and a higher infection–fatality ratio in the urban community. Approximately 95% of SARS-CoV-2 infections were not reported to national surveillance.
format Online
Article
Text
id pubmed-8632160
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-86321602021-12-01 SARS-CoV-2 Seroprevalence in a Rural and Urban Household Cohort during First and Second Waves of Infections, South Africa, July 2020–March 2021 Kleynhans, Jackie Tempia, Stefano Wolter, Nicole von Gottberg, Anne Bhiman, Jinal N. Buys, Amelia Moyes, Jocelyn McMorrow, Meredith L. Kahn, Kathleen Gómez-Olivé, F. Xavier Tollman, Stephen Martinson, Neil A. Wafawanaka, Floidy Lebina, Limakatso du Toit, Jacques Jassat, Waasila Neti, Mzimasi Brauer, Marieke Cohen, Cheryl Emerg Infect Dis Research Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections may be underestimated because of limited access to testing. We measured SARS-CoV-2 seroprevalence in South Africa every 2 months during July 2020–March 2021 in randomly selected household cohorts in 2 communities. We compared seroprevalence to reported laboratory-confirmed infections, hospitalizations, and deaths to calculate infection–case, infection–hospitalization, and infection–fatality ratios in 2 waves of infection. Post–second wave seroprevalence ranged from 18% in the rural community children <5 years of age, to 59% in urban community adults 35–59 years of age. The second wave saw a shift in age distribution of case-patients in the urban community (from persons 35–59 years of age to persons at the extremes of age), higher attack rates in the rural community, and a higher infection–fatality ratio in the urban community. Approximately 95% of SARS-CoV-2 infections were not reported to national surveillance. Centers for Disease Control and Prevention 2021-12 /pmc/articles/PMC8632160/ /pubmed/34477548 http://dx.doi.org/10.3201/eid2712.211465 Text en https://creativecommons.org/licenses/by/4.0/Emerging Infectious Diseases is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Research
Kleynhans, Jackie
Tempia, Stefano
Wolter, Nicole
von Gottberg, Anne
Bhiman, Jinal N.
Buys, Amelia
Moyes, Jocelyn
McMorrow, Meredith L.
Kahn, Kathleen
Gómez-Olivé, F. Xavier
Tollman, Stephen
Martinson, Neil A.
Wafawanaka, Floidy
Lebina, Limakatso
du Toit, Jacques
Jassat, Waasila
Neti, Mzimasi
Brauer, Marieke
Cohen, Cheryl
SARS-CoV-2 Seroprevalence in a Rural and Urban Household Cohort during First and Second Waves of Infections, South Africa, July 2020–March 2021
title SARS-CoV-2 Seroprevalence in a Rural and Urban Household Cohort during First and Second Waves of Infections, South Africa, July 2020–March 2021
title_full SARS-CoV-2 Seroprevalence in a Rural and Urban Household Cohort during First and Second Waves of Infections, South Africa, July 2020–March 2021
title_fullStr SARS-CoV-2 Seroprevalence in a Rural and Urban Household Cohort during First and Second Waves of Infections, South Africa, July 2020–March 2021
title_full_unstemmed SARS-CoV-2 Seroprevalence in a Rural and Urban Household Cohort during First and Second Waves of Infections, South Africa, July 2020–March 2021
title_short SARS-CoV-2 Seroprevalence in a Rural and Urban Household Cohort during First and Second Waves of Infections, South Africa, July 2020–March 2021
title_sort sars-cov-2 seroprevalence in a rural and urban household cohort during first and second waves of infections, south africa, july 2020–march 2021
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632160/
https://www.ncbi.nlm.nih.gov/pubmed/34477548
http://dx.doi.org/10.3201/eid2712.211465
work_keys_str_mv AT kleynhansjackie sarscov2seroprevalenceinaruralandurbanhouseholdcohortduringfirstandsecondwavesofinfectionssouthafricajuly2020march2021
AT tempiastefano sarscov2seroprevalenceinaruralandurbanhouseholdcohortduringfirstandsecondwavesofinfectionssouthafricajuly2020march2021
AT wolternicole sarscov2seroprevalenceinaruralandurbanhouseholdcohortduringfirstandsecondwavesofinfectionssouthafricajuly2020march2021
AT vongottberganne sarscov2seroprevalenceinaruralandurbanhouseholdcohortduringfirstandsecondwavesofinfectionssouthafricajuly2020march2021
AT bhimanjinaln sarscov2seroprevalenceinaruralandurbanhouseholdcohortduringfirstandsecondwavesofinfectionssouthafricajuly2020march2021
AT buysamelia sarscov2seroprevalenceinaruralandurbanhouseholdcohortduringfirstandsecondwavesofinfectionssouthafricajuly2020march2021
AT moyesjocelyn sarscov2seroprevalenceinaruralandurbanhouseholdcohortduringfirstandsecondwavesofinfectionssouthafricajuly2020march2021
AT mcmorrowmeredithl sarscov2seroprevalenceinaruralandurbanhouseholdcohortduringfirstandsecondwavesofinfectionssouthafricajuly2020march2021
AT kahnkathleen sarscov2seroprevalenceinaruralandurbanhouseholdcohortduringfirstandsecondwavesofinfectionssouthafricajuly2020march2021
AT gomezolivefxavier sarscov2seroprevalenceinaruralandurbanhouseholdcohortduringfirstandsecondwavesofinfectionssouthafricajuly2020march2021
AT tollmanstephen sarscov2seroprevalenceinaruralandurbanhouseholdcohortduringfirstandsecondwavesofinfectionssouthafricajuly2020march2021
AT martinsonneila sarscov2seroprevalenceinaruralandurbanhouseholdcohortduringfirstandsecondwavesofinfectionssouthafricajuly2020march2021
AT wafawanakafloidy sarscov2seroprevalenceinaruralandurbanhouseholdcohortduringfirstandsecondwavesofinfectionssouthafricajuly2020march2021
AT lebinalimakatso sarscov2seroprevalenceinaruralandurbanhouseholdcohortduringfirstandsecondwavesofinfectionssouthafricajuly2020march2021
AT dutoitjacques sarscov2seroprevalenceinaruralandurbanhouseholdcohortduringfirstandsecondwavesofinfectionssouthafricajuly2020march2021
AT jassatwaasila sarscov2seroprevalenceinaruralandurbanhouseholdcohortduringfirstandsecondwavesofinfectionssouthafricajuly2020march2021
AT netimzimasi sarscov2seroprevalenceinaruralandurbanhouseholdcohortduringfirstandsecondwavesofinfectionssouthafricajuly2020march2021
AT brauermarieke sarscov2seroprevalenceinaruralandurbanhouseholdcohortduringfirstandsecondwavesofinfectionssouthafricajuly2020march2021
AT cohencheryl sarscov2seroprevalenceinaruralandurbanhouseholdcohortduringfirstandsecondwavesofinfectionssouthafricajuly2020march2021
AT sarscov2seroprevalenceinaruralandurbanhouseholdcohortduringfirstandsecondwavesofinfectionssouthafricajuly2020march2021